Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Promising cancer treatments were found, but the manufacturer closed.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Targeting THY1 can improve skin repair and healing.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.

New compounds may help treat heart disease by activating specific potassium channels.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Abrocitinib may effectively treat stubborn alopecia universalis.

Upadacitinib may effectively treat alopecia areata without side effects.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Janus kinase inhibitors may help treat lichen planopilaris.